MICHAEL DUNKER: Open Payments
NPI 1487215604 · TROY, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,643 in 178 payments from 14 companies in 2025. Trend: 2023 $2,942 · 2024 $2,639 · 2025 $2,643
Food & beverage: $2,632Education: $11
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 30 | $376 |
| Otsuka America Pharmaceutical, Inc. | 16 | $359 |
| Lundbeck LLC | 21 | $314 |
| ABBVIE INC. | 37 | $261 |
| Supernus Pharmaceuticals, Inc. | 13 | $243 |
| Teva Pharmaceuticals USA, Inc. | 12 | $232 |
| Neurocrine BioSciences, Inc. | 10 | $229 |
| Alkermes, Inc. | 11 | $192 |
| E.R. Squibb & Sons, L.L.C. | 15 | $166 |
| Vanda Pharmaceuticals Inc. | 4 | $114 |
Products named: REXULTI, INVEGA SUSTENNA, VRAYLAR, Qelbree, INGREZZA, ARISTADA, COBENFY, AUSTEDO XR.
Industry payments across OH — which companies pay providers there.
